临床药讯10年第2期.pdfVIP

2010 年第 2 期 · 总第 期 本 期 目 录 药物研究进展 他汀类药物对神经系统疾病治疗研究进展 ········································································1· 合理用药 维生素类药物的使用误区 ····································································································5· 不合理用药医嘱分析 4 例 ····································································································6· 不合格处方点评 2 例 ············································································································6· 药物警戒 警惕阿昔洛韦致急性肾衰 ····································································································8· 欧盟警告短效 β受体激动剂引起心肌缺血风险 ································································8· 美国 FDA警告静脉注射异丙嗪可致严重组织损伤 ····························································9· 国内外药物信息 诺华公司修订麦考酚酸说明书警示贫血风险 ···································································11 美国 FDA警告氯吡格雷与奥美拉唑的相互作用 ·······························································12 药品不良反应 我院 2009 年药品不良反应报告分析 ·················································································13 新药介绍 曲匹地尔片 ···························································································································17 依帕司他片 ···························································································································18 临床药讯电子版 2010 年第 1 期 药物研究进展 他汀类药物对神经系统疾病治疗研究进展 大量循证研究结果表明， 羟甲基戊二酰辅酶 A(HMG-CoA)还原酶抑制药 （简称他汀类药物） 在多种心血管疾病的预防和治疗中发挥重要作用。 本文对他汀类药物在卒中、 阿尔采末病 （又 名阿尔茨海默病）、帕金森病和多发性硬化等多种神经